{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:40:12Z","timestamp":1781664012978,"version":"3.54.5"},"reference-count":23,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Recurrent urinary tract infections (rUTIs) are highly prevalent health issues among women, significantly impacting their quality of life. Urethral pain or urethritis can arise from infectious or non-infectious origins. The presence of Human Papillomavirus (HPV) in the urogenital tract has been associated with high-risk sexual behaviors, but its presence in the female urethra without such behaviors has not been thoroughly investigated. Objectives: The study aims to determine the presence of HPV in the urethra of women with recurrent urinary tract infections (rUTIs) and concomitant urethral syndrome and to compare the clinical and microbiological characteristics of women with and without urethral HPV, specifically focusing on those without high-risk sexual behaviors. Methods: This prospective multicenter study included 138 women over 18 years old with rUTIs and concomitant urethral pain syndrome. High-risk sexual behaviors, sexually transmitted infections, and vaginitis were set as exclusion criteria. Participants were divided into two groups: NHPV (n = 72) with no urethral HPV and HPV (n = 66) with urethral HPV presence. Variables analyzed included age, body mass index (BMI), follow-up duration, comorbidities, treatments, toxic habits, surgical history, main symptoms, urine sediment findings, and cultures from urine and vaginal exudate. HPV genotyping was also performed. Descriptive statistics were used, along with Student\u2019s t-test, Chi-square, Fisher\u2019s exact test, ANOVA, and multivariate cluster analysis. Results: The NHPV group was older on average (48.75 years) compared to the HPV group (39.09 years). The HPV group had a longer follow-up period (2634 days vs. 1975 days in NHPV). Urinary incontinence was significantly more common in NHPV (63.89%) compared to HPV (18.18%) (p = 0.001). HPV-positive women had a higher prevalence of verrucous lesions in the vaginal introitus (64% vs. 8% in NHPV). Additionally, the HPV group showed higher rates of pyuria (27.27%), vaginal Candida albicans (36.26%), and positive urine cultures for Escherichia coli (47.83%), Enterococcus faecalis (36.36%), and Klebsiella pneumoniae (21.74%). No significant differences were observed between the groups concerning BMI, smoking habits, diabetes, or the main symptom at consultation. The most common HPV genotypes identified were G35, G42, and G66 (each 27%). Multivariate analysis revealed that sensitivity to nitrofurantoin was the most significant variable in the HPV group (importance of 0.96), followed by fosfomycin (0.79), trimethoprim (0.79), and amoxicillin (0.71). Conclusions: HPV was present in the urethra of 47.8% of women with rUTIs and concomitant urethral syndrome who did not exhibit high-risk sexual behaviors. These women were younger and had a longer duration of symptoms compared to those without urethral HPV. The identification of Enterococcus faecalis, Escherichia coli, and Klebsiella pneumoniae was more common in the HPV group. The sensitivity of bacteria to nitrofurantoin and fosfomycin is crucial for the clinical management of these patients. The presence of urethral HPV should be considered in the evaluation and treatment of women with rUTIs and urethral syndrome.<\/jats:p>","DOI":"10.3390\/jcm13175329","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T05:06:06Z","timestamp":1725858366000},"page":"5329","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between the Presence of Human Papillomavirus in the Female Urethra and Recurrent Urinary Tract Infections"],"prefix":"10.3390","volume":"13","author":[{"given":"Cristina","family":"Mena-Ruiz","sequence":"first","affiliation":[{"name":"Department of Urology, University Hospital of Araba, 01009 \u00c1lava, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-5692","authenticated-orcid":false,"given":"Julius Jan","family":"Szczesnieski","sequence":"additional","affiliation":[{"name":"Department of Urology, University Hospital of Getafe, 28905 Getafe, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-0118","authenticated-orcid":false,"given":"Magaly","family":"M\u00e1rquez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Renal Urological Multidisciplinary Research Group (GRUMUR), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-6033","authenticated-orcid":false,"given":"B\u00e1rbara-Yolanda","family":"Padilla-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Urology, Surgery Department, University of La Laguna, 38200 Santa Cruz de Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-0551","authenticated-orcid":false,"given":"Javier","family":"Flores-Fraile","sequence":"additional","affiliation":[{"name":"Renal Urological Multidisciplinary Research Group (GRUMUR), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain"},{"name":"Surgery Department, University of Salamanca, 37007 Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Fernanda","family":"Lorenzo-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Renal Urological Multidisciplinary Research Group (GRUMUR), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain"},{"name":"Surgery Department, University of Salamanca, 37007 Salamanca, Spain"},{"name":"Department of Urology, University Hospital of Salamanca, 37007 Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lyu, Z., Feng, X., Li, N., Zhao, W., Wei, L., Chen, Y., Yang, W., Ma, H., Yao, B., and Zhang, K. (2017). Human papillomavirus in semen and the risk for male infertility: A systematic review and meta-analysis. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2812-z"},{"key":"ref_2","unstructured":"(2024, June 11). EAU-Guidelines-on-Urological-Infections-2024. Available online: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Urological-Infections-2024.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-\u00c1lvarez, M.I., G\u00f3mez-Urquiza, J.L., Husein-El Ahmed, H., Albend\u00edn-Garc\u00eda, L., G\u00f3mez-Salgado, J., and Ca\u00f1adas-De la Fuente, G.A. (2018). Prevalence and Risk Factors of Human Papillomavirus in Male Patients: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15102210"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jiac.2014.08.033","article-title":"Human papillomavirus infection and pathogenesis in urothelial cells: A mini-review","volume":"20","author":"Shigehara","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-5347(17)34870-X","article-title":"A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: Polymerase chain reaction-based analysis of multiple histological types","volume":"151","author":"Wiener","year":"1994","journal-title":"J. Urol."},{"key":"ref_6","first-page":"208","article-title":"Detection of Human PapillomavirusType 16 DNA Sequences in Paraffin-Embedded Tissues from the Female Urinary Tract","volume":"52","author":"Gazzaniga","year":"2010","journal-title":"Urol. Int."},{"key":"ref_7","first-page":"EVIDoa2100018","article-title":"Sublingual MV140 for Prevention of Recurrent Urinary Tract Infections","volume":"1","author":"Foley","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wang, R., Huang, H., Yu, C., Li, X., Wang, Y., and Xie, L. (2024). Current status and future directions for the development of human papillomavirus vaccines. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1362770"},{"key":"ref_9","first-page":"427","article-title":"The association between the human papillomavirus (HPV) and the diagnosis of bladder cancer: Systematic review and meta-analysis","volume":"48","year":"2024","journal-title":"Actas Urol. Esp."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18565\/urology.2024.1.10-16","article-title":"Immunological parameters of urine in differential diagnosis of chronic recurrent cystitis in women","volume":"1","author":"Ibishev","year":"2024","journal-title":"Urologiia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2053369120936426","article-title":"Interstitial cystitis\/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome","volume":"26","author":"Bhide","year":"2020","journal-title":"Post Reprod. Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00192-020-04397-z","article-title":"Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: A meta-analysis of randomized controlled trials","volume":"32","author":"Chen","year":"2021","journal-title":"Int. Urogynecol. J."},{"key":"ref_13","first-page":"1038","article-title":"HPV and urinary bladder carcinoma: A review of the literature","volume":"5","author":"Visalli","year":"2018","journal-title":"World Cancer Res. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Walker","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajog.2016.07.040","article-title":"Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: A systematic review and meta-analysis","volume":"215","author":"Price","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e015233","DOI":"10.1136\/bmjopen-2016-015233","article-title":"Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: Systematic review and meta-analysis of randomised trials","volume":"7","author":"Ahmed","year":"2017","journal-title":"BMJ Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/iju.IJU_378_18","article-title":"The use of chemotherapeutic agents as prophylaxis for recurrent urinary tract infection in healthy nonpregnant women: A network meta-analysis","volume":"35","author":"Nalliah","year":"2019","journal-title":"Indian. J. Urol."},{"key":"ref_18","first-page":"560","article-title":"Common Questions About Recurrent Urinary Tract Infections in Women","volume":"93","author":"Arnold","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lorenzo-G\u00f3mez, M.F., Padilla-Fern\u00e1ndez, B., Garc\u00eda-Cenador, M.B., Virseda-Rodr\u00edguez, \u00c1.J., Mart\u00edn-Garc\u00eda, I., S\u00e1nchez-Escudero, A., Vicente-Arroyo, M.J., and Mir\u00f3n-Canelo, J.A. (2015). Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections. Front. Cell Infect. Microbiol., 5.","DOI":"10.3389\/fcimb.2015.00050"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Martin-Cruz, L., Sevilla-Ortega, C., Benito-Villalvilla, C., Diez-Rivero, C.M., Sanchez-Ram\u00f3n, S., Subiza, J.L., and Palomares, O. (2021). A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.612269"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/mi.2016.112","article-title":"MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88","volume":"10","author":"Cirauqui","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.27608","article-title":"A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination","volume":"132","author":"Wheeler","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.eururo.2013.03.044","article-title":"EAU Guidelines on Primary Urethral Carcinoma","volume":"64","author":"Gakis","year":"2013","journal-title":"Eur. Urol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/17\/5329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:51:55Z","timestamp":1760111515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/17\/5329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":23,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["jcm13175329"],"URL":"https:\/\/doi.org\/10.3390\/jcm13175329","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]}}}